Beihai Gofar Chuanshan Biological (600538) Stock Overview
Beihai Gofar Chuanshan Biological Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
600538 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Beihai Gofar Chuanshan Biological Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.95 |
| 52 Week High | CN¥6.40 |
| 52 Week Low | CN¥2.90 |
| Beta | 0.10 |
| 1 Month Change | 11.22% |
| 3 Month Change | 22.18% |
| 1 Year Change | 70.00% |
| 3 Year Change | 18.53% |
| 5 Year Change | -29.50% |
| Change since IPO | 5.37% |
Recent News & Updates
Recent updates
Optimistic Investors Push Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) Shares Up 32% But Growth Is Lacking
Oct 18
Investor Optimism Abounds Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) But Growth Is Lacking
Jul 12Beihai Gofar Chuanshan Biological Co., Ltd.'s (SHSE:600538) Shares Climb 34% But Its Business Is Yet to Catch Up
Mar 08Shareholder Returns
| 600538 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 6.8% | 1.9% | 1.3% |
| 1Y | 70.0% | 21.9% | 26.0% |
Return vs Industry: 600538 exceeded the CN Chemicals industry which returned 21.9% over the past year.
Return vs Market: 600538 exceeded the CN Market which returned 26% over the past year.
Price Volatility
| 600538 volatility | |
|---|---|
| 600538 Average Weekly Movement | 3.8% |
| Chemicals Industry Average Movement | 4.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 2.8% |
Stable Share Price: 600538 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600538's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 453 | Bin Pan Li | www.gofar.com.cn |
Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eye drops, pearl powder, nacre powder, weichangning granules, and forensic identification technical services, etc. It is also involved in providing DNA testing equipment; sells consumables and testing services; and art sales.
Beihai Gofar Chuanshan Biological Co., Ltd. Fundamentals Summary
| 600538 fundamental statistics | |
|---|---|
| Market cap | CN¥3.12b |
| Earnings (TTM) | -CN¥78.35m |
| Revenue (TTM) | CN¥331.51m |
Is 600538 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600538 income statement (TTM) | |
|---|---|
| Revenue | CN¥331.51m |
| Cost of Revenue | CN¥248.88m |
| Gross Profit | CN¥82.63m |
| Other Expenses | CN¥160.98m |
| Earnings | -CN¥78.35m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 22, 2025
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 24.93% |
| Net Profit Margin | -23.63% |
| Debt/Equity Ratio | 0.1% |
How did 600538 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/19 00:21 |
| End of Day Share Price | 2025/07/18 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beihai Gofar Chuanshan Biological Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.